Subscribe to MDT Magazine News

Tips For Enjoying A Healthy And Balanced Life

April 14, 2011 11:34 am | by Bio-Medicine.Org | Comments

SHENZHEN, China, April 14, 2011 /PRNewswire-Asia/ In today's modern high-tempo society, people always live a rapid pace of life . Fast food gets more and more popular especially in modern societies in which time is money. People also realize the importance of heath; they pay great...


Filtering out pesticides with E. coli

April 14, 2011 10:40 am | by EurekAlert | Comments

(Inderscience Publishers) Genetically modified bacteria could be used in air filters to extract pesticide vapors from polluted air thanks to work by researchers in China published this month in the International Journal of Environment and Pollution.

Tourette Syndrome: non-drug therapy to reduce tics

April 14, 2011 9:40 am | by EurekAlert | Comments

(University of Montreal) The use of cognitive-behavioral therapy to treat tics in Tourette syndrome may be as effective as and even superior to medication in certain cases. According to a new study published in a special edition of the International Journal of Cognitive Therapy by...


Covidien's updated spine sealant approved by FDA

April 14, 2011 9:36 am | by Mass High Tech: The Journal of New England Technology | Comments

The U.S. Food and Drug Administration has approved Covidien plc's DuraSeal Exact, a spine sealant designed as an improved version of the company's already approved DuraSeal.


Results From Largest Study of Anti-Rejection Therapy for Heart Transplant Patients Will be Released at ISHLT Meeting

April 14, 2011 9:34 am | by Bio-Medicine.Org | Comments

SAN DIEGO, April 14, 2011 /- New results from the largest multicenter clinical trial for heart transplant patients will be released this week at the International Society for Heart & Lung Transplantation (ISHLT) 31st Annual Meeting and Scientific Sessions in San Diego.  Results...

Transgenomic, Inc. Expands SURVEYOR® Scan Product Line With BRAF and PIK3CA Mutation Detection Kits

April 14, 2011 9:33 am | by Bio-Medicine.Org | Comments

OMAHA, Neb., April 14, 2011 /- Transgenomic, Inc. (OTC/BB: TBIO) announced today that it has launched kits for high sensitivity mutational analysis of the BRAF and PIK3CA genes. These new kits complement the company's existing kits for detecting mutations in K-RAS , expanding...


BT Pushes for R & D Innovation at Bio-IT World Conference

April 14, 2011 9:33 am | by Bio-Medicine.Org | Comments

BOSTON, April 14, 2011 /- BT (NYSE: BT ) shared its vision of the future of pharma R&D and the application of cloud computing strategies to pharma research at the Bio-IT World Conference & Expo held this week in Boston. This vision reflects BT's strong capabilities and increasing...


Sector Snap: For-profit hospital operators

April 14, 2011 8:45 am | by The Associated Press | Comments

A Jefferies & Co. analyst said Thursday that shares of hospital operators should trade higher in the coming months as patient admission volumes stabilize and consolidation continues.Analyst Arthur Henderson said hospitals will continue to gain more business as the U.S. economy recovers, and...


Federal Register: Guidance for Industry and Food and Drug Administration Staff; 30-Day Notices, 135-Day Premarket Approval Supplements and 75-Day Humanitarian Device Exemption...

April 14, 2011 7:36 am | by U.S. Food & Drug Administration | Comments

This document provides guidance on the type of changes to an approved application that FDA believes may qualify for submission as 30-day notices, the type of information to submit in a 30-day notice, and the user fees associated with these submissions...

Guidance for Industry and FDA Staff - 30-Day Notices, 135-Day Premarket Approval (PMA) Supplements and 75-Day Humanitarian Device Exemption (HDE) Supplements for Manufacturing...

April 14, 2011 7:36 am | by U.S. Food & Drug Administration | Comments

Section 515(d)(6)(A) of the Federal Food, Drug, and Cosmetic Act (the Act) provides that PMA supplements are required for any change to a device subject to an approved application that affects safety or effectiveness, unless such change is a...

Dynatronics Regains Compliance With NASDAQ

April 14, 2011 7:36 am | by Bio-Medicine.Org | Comments

SALT LAKE CITY, April 14, 2011 /- Dynatronics Corporation (NASDAQ: DYNT ) today announced that the company has received a letter from NASDAQ stating that Dynatronics has regained compliance with the $1.00 minimum bid requirement for listing on that exchange. "By curing the $1 minimum bid...


Sanare Launches BrightSky, a New Consumer Brand Serving People Living With Diabetes

April 14, 2011 7:36 am | by Bio-Medicine.Org | Comments

RENO, Nev., April 14, 2011 /- Sanare, LLC, a leading provider of care management solutions for people with diabetes, announced today the launch of its new consumer brand, BrightSky. (Logo: BrightSky is the backbone of Sanare's value...


Spine Pain Management, Inc. Conference Call and Webcast Reminder and Instructions

April 14, 2011 7:35 am | by Bio-Medicine.Org | Comments

HOUSTON, April 14, 2011 /- Spine Pain Management, Inc., (OTC BB: SPIN) through its CEO, Dr. William Donovan would like to invite all Investors and interested parties to participate in the Company's first interactive phone and web-based conference call with PowerPoint presentation. During...


ERT Awarded over $10 Million of ePRO Business from Major Pharma – Increasing its Position as a Leading ePRO Provider

April 14, 2011 7:33 am | by RealWire | Comments

PHILADELPHIA, PA - 14 April 2011 ERT, a global technology-driven provider of clinical services and customizable medical devices to biopharmaceutical and healthcare organizations, announced today that it was awarded three new contracts with top tier pharmaceutical companies, totaling over...

Tumor Necrosis Factor (TNF) blockers, Azathioprine and/or Mercaptopurine: Update on Reports of Hepatosplenic T-Cell Lymphoma in Adolescents and Young Adults

April 14, 2011 7:30 am | by U.S. Food & Drug Administration | Comments

FDA continues to receive reports of a rare cancer of white blood cells.


You may login with either your assigned username or your e-mail address.
The password field is case sensitive.